New Celiac Disease Panel Offers Promising, New Diagnostic Tools To Aid Doctors, Patients

New Celiac Disease Panel Offers Promising, New Diagnostic Tools To Aid Doctors, Patients
SQI Diagnostics Inc., a company that designs and commercializes technology for advanced microarray diagnostics, recently announced that the FDA has given approval for the commercialization of its product, a Celiac Panel, in the United States. This new technology will allow for improved celiac disease-affected individuals’ diagnosis. Celiac disease is an autoimmune disease of the small intestine

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *